Solazyme executives are focused on long-term strategies, such as updating technology at the company's industrial fermentation facility in Brazil, even if it results in short-term decline in stock values, writes Kevin Quon. CEO Jonathan Wolfson and his management team display "disciplined restraint and prudence," in their decisions, such as opting out of deals that don't mesh well with the company's long-term goals, Quon writes.

Related Summaries